ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Human Tissue Available Through NCI Network

July 10, 1987

Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths

April 22, 1994

ACS Asks Higher NCI Authorization

March 24, 1978

In Brief: Abeloff Directs John Hopkins Oncology Center; Claudia Baquet Named Deputy Secretary In HHS

September 25, 1992

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978